Kurzrock R

No ORCID on file · 3 papers in corpus · active 2020-2026

Study types

  • review 2

Condition tags

  • endometriosis 2
2026
Journal for immunotherapy of cancer ·doi:10.1136/jitc-2025-012805

BackgroundDual anti-CTLA-4/PD-1 inhibitors show efficacy in numerous malignancies. We are the first to report on the efficacy of ipilimumab-nivolumab immunotherapy in a dedicated cohort of patients with gynecologic clear cell carcinomas (CC…

review 2024
Med (New York, N.Y.) ·doi:10.1016/j.medj.2024.04.008

Growth and immune process dysregulation can result in both cancer and nonmalignant disease (hereditary or acquired, with and without predisposition to malignancy). Moreover, perhaps unexpectedly, many nonmalignant illnesses harbor genomic a…

review 2020
Genome medicine ·doi:10.1186/s13073-020-0714-y

Next-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures. Intriguingly, rapidly emerging data indicate that altered genes…